|
|
38 Sidney Street
Cambridge, MA 02139 USA
phone:617 577 7270
fax:617 577 7170
|
|
| Symbol |
Private |
| Founded |
0 |
| Employees |
|
|
|
| www.etexcorp.com
|
|
| Research Sector |
Medical Devices & Tech |
|
 |
| Summary Description |
| Bone graft substitutes, implant surface coatings, and resorbable orthopedic devices. |
|
| Management |
| Brian T. Ennis, President and Chief Executive Officer; Pamela W. Adams, B.S., S.M., R.A.C., C.Q.M., Senior Vice President and Chief Operating Officer; Steve Kim, Vice President and Chief Financial Officer; Jeffrey A. Wellkamp, Vice President of Sales; Jerry Chang, Ph.D., Senior Director Research & Development; Aliassghar Tofighi, Ph.D., Distinguished Research Fellow; Charles J. Capps, B.S., M.B.A., Director, Manufacturing Operations
|
| |
|
|
| |
|
| Keywords |
| Orthopedics, spine, ortho joint, reconstruction, ortho joint, reconstruction, advamed |
|
|
|
| Description |
|
ETEX specializes in the development of calcium phosphate-based bone graft substitutes, implant surface coatings, and resorbable orthopedic devices. |
|
| Products / Services |
ETEX's first product, alpha-BSM Bone Substitute Material, is used for the treatment of bone voids resulting from fractures and other medical conditions.
Other products currently in ETEX's research pipeline include development of bone graft substitutes suitable for reconstruction of skeletal defects, carrier formulations for delivering recombinant human Bone Morphogenic Protein-2 (rhBMP-2) for various orthopaedic and spine indications and resorbable orthopaedic implants.
|
|
|
|
|
|
|
|
|
Biotech & Specialty Pharma
Healthcare Services
Medical Devices & Tech
OneMedPlace Member
AdvaMed Members